A Single Center Real-world Study of Donafenib in the Treatment of Hepatocellular Carcinoma in Routine Clinical Practice
Clinical trial NCT05200221 · UNKNOWN
Trial details
- NCT number
- NCT05200221
- Sponsor
- Shanghai Zhongshan Hospital
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2022-01-19
- Primary completion
- 2024-01-30
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.